BEIJING, Feb. 8 (Xinhua) -- A total of 1,073 A-share companies, accounting for over 40 percent of the comparable aggregate, released by Tuesday optimistic projections for their annual financial performance in 2022, reported Xinhua-run China Securities Journal on Wednesday.
These companies, including those predicting profit growth, continued profitability, slight profit increase and shift from loss-making to profitability for last year, numbered 672, 30, 140 and 200-plus ones respectively, showed data with Wind, a financial information provider in China.
Most of them are from computer, special-purpose equipment manufacturing, electrical, chemical, and pharmaceutical sectors, with corresponding A-share companies forecasting optimistic annual results totaling 140, 104, 95, 82 and 71 ones.
After long lasting fluctuations, computer companies listed on China's A-share market posted relatively outstanding performance since the beginning of 2023. Among the 140 computer firms that released optimistic 2022 financial results, as many as 27 ones foresaw their net profits to surge by at least 100 percent from 2021.
Pharmaceutical industry turned out another sector that large institutional investors continued to bet on recently. In general, 35 of the 71 optimistic results forecasters in the sector expected their annual profit for 2022 to grow by at least 100 percent from the previous year.
For the rest of 2023, experts believed that the financial performance of A-share market-listed firms was likely to gradually recover, especially for those engaged in mid- and downstream industries.
For short-term investors, market players suggest that real estate, computer, and semiconductor sectors that may hail growth momentum recovery are suitable. For mid- and long-term investors, consumption and medical A-shares are worthy of further attention. (Edited by Duan Jing with Xinhua Silk Road, duanjing@xinhua.org)
A single purchase
